This book is a compilation of the bench experience of leading experts from various research
labs involved in the cutting edge area of research. The authors describe the use of stem cells
both as part of the combinatorial therapeutic intervention approach and as tools (disease
model) during drug development highlighting the shift from a conventional symptomatic
treatment strategy to addressing the root cause of the disease process. The book is a continuum
of the previously published book entitled Stem Cells: from Drug to Drug Discovery which was
published in 2017.
